HEALTH● LOW3h ago · Sep 28, 2026, 5:45 PM
Retatrutide Diabetes Results , Mounjaro Heart Data , and Wegovy Pill Switching Study Lead EASD 2026 Meeting Opening in Milan
medicaldaily.com · United States · western europe
Key research findings on diabetes drug Retatrutide, heart data for Mounjaro, and a Wegovy pill switching study were presented at the opening of the EASD 2026 Meeting in Milan. This showcases new developments in medical treatments and research.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
See it on the live mapUnited States and nearby eventsMore from United StatesLatest stories and threat level
More from United States
WORLD47m agoMTSU Derek Mason sounds off on Conference united states officiating after loss to Jax State – MTSU Sidelinesmtsusidelines.com · United StatesPOLITICS1h agoUnited States revokes visas for Euclides Torres and Martha PeraltaLa Silla VacíaMILITARY14h agoAntonio Mancebo, combat pilot, on the world's most powerful air forces: "The United States has an insurmountable war machine"ClarínSCI & TECH15h agoAre global controls needed for AI? The United States doesn’t think soIrish Times World
More in Health
HEALTH2h agoBlood pressure medication recalled nationwide under FDA’s Class II risk levelThe HillHEALTH3h agoNational Medicine Collection Campaign: how to help those who cannot access remediesClarínHEALTH3h agoMadin Academy launches anti-drug initiative under ‘Operation Toofan’The HinduHEALTH3h agoHospitals in Visakhapatnam mark World Heart Day with focus on early detectionThe Hindu